Wilhelm- Anton- Hospital gGmbH
Goch, Germany
General hospital in Goch, North Rhine-Westphalia
Voßheider Str. 214, 47574 Goch
About Wilhelm- Anton- Hospital gGmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
12
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
Heinrich-Heine University, Duesseldorf
1
Hoffmann-La Roche
1
Jurgen Barth
1
Nektar Therapeutics
1
University of Erlangen-Nürnberg Medical School
1
Clinical Trials at Wilhelm- Anton- Hospital gGmbH
During the past decade, Wilhelm- Anton- Hospital gGmbH conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)
2004-06-01
2009-06-01
Completed
95
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
2004-07-01
2013-08-01
Completed
920
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
2004-06-01
2011-01-01
Completed
500
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
2004-01-01
Unknown status
1,234
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
2006-07-01
2016-06-01
Completed
1,256
Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
2009-06-01
2015-11-01
Completed
89
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Wilhelm- Anton- Hospital gGmbH" #1 sponsor was "University of Ulm" with 12 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials
sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Wilhelm- Anton- Hospital gGmbH"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Wilhelm- Anton- Hospital gGmbH
According to Clinical.Site data, the most researched conditions in "Wilhelm- Anton- Hospital gGmbH" are
"Acute Myeloid Leukemia" (7 trials), "Acute Myeloid Leukemia (AML)" (6 trials), "Lymphoma" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials). Many other conditions were trialed in "Wilhelm- Anton- Hospital gGmbH" in a lesser frequency.
Clinical Trials Intervention Types at Wilhelm- Anton- Hospital gGmbH
Most popular intervention types in "Wilhelm- Anton- Hospital gGmbH" are "Drug" (19 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cytarabine" (9 trials), "Idarubicin" (4 trials), "Daunorubicin" (3 trials), "Etoposide" (3 trials) and "Mitoxantrone" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Wilhelm- Anton- Hospital gGmbH
The vast majority of trials in "Wilhelm- Anton- Hospital gGmbH" are
19 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Wilhelm- Anton- Hospital gGmbH
Currently, there are NaN active trials in "Wilhelm- Anton- Hospital gGmbH".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Wilhelm- Anton- Hospital gGmbH,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Wilhelm- Anton- Hospital gGmbH, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".